CN118891273A - 膜联蛋白a1衍生的多肽类似物 - Google Patents

膜联蛋白a1衍生的多肽类似物 Download PDF

Info

Publication number
CN118891273A
CN118891273A CN202380023372.3A CN202380023372A CN118891273A CN 118891273 A CN118891273 A CN 118891273A CN 202380023372 A CN202380023372 A CN 202380023372A CN 118891273 A CN118891273 A CN 118891273A
Authority
CN
China
Prior art keywords
lys
polypeptide
seq
amino acid
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380023372.3A
Other languages
English (en)
Chinese (zh)
Inventor
托马斯·恩格尔布雷希特·诺克尔德·约纳森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lesoth Pharmaceutical Co ltd
Original Assignee
Lesoth Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lesoth Pharmaceutical Co ltd filed Critical Lesoth Pharmaceutical Co ltd
Publication of CN118891273A publication Critical patent/CN118891273A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721Lipocortins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202380023372.3A 2022-02-23 2023-02-23 膜联蛋白a1衍生的多肽类似物 Pending CN118891273A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22158253 2022-02-23
EP22158253.9 2022-02-23
PCT/EP2023/054519 WO2023161323A1 (en) 2022-02-23 2023-02-23 Annexin a1-derived polypeptide analogues

Publications (1)

Publication Number Publication Date
CN118891273A true CN118891273A (zh) 2024-11-01

Family

ID=80461005

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380023372.3A Pending CN118891273A (zh) 2022-02-23 2023-02-23 膜联蛋白a1衍生的多肽类似物

Country Status (7)

Country Link
US (1) US20250388632A1 (https=)
EP (1) EP4482853A1 (https=)
JP (1) JP2025506775A (https=)
CN (1) CN118891273A (https=)
AU (1) AU2023226134A1 (https=)
CA (1) CA3249181A1 (https=)
WO (1) WO2023161323A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025083393A1 (en) * 2023-10-16 2025-04-24 Therakind Limited Antimicrobial use of peptides derived from annexin a1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002364607A1 (en) * 2001-12-28 2003-07-24 The Burnham Institute Novel ligand involved in the transmigration of leukocytes .
FR2856069A1 (fr) * 2003-06-10 2004-12-17 Bionexis Molecules de ciblage et de liberation de composes therapeutiques et leur utilisation
US9102753B2 (en) 2011-06-15 2015-08-11 Ugp Therapeutics, Inc. Anti-inflammatory pharmaceutical products
KR20150029457A (ko) * 2013-09-10 2015-03-18 삼성전자주식회사 아넥신 a1에 결합하는 폴리펩타이드 및 그의 용도
JP2017513875A (ja) 2014-04-22 2017-06-01 ティーエックスピー ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング 分枝状アミノ酸プローブを有するペプチド類似体

Also Published As

Publication number Publication date
AU2023226134A1 (en) 2024-08-01
EP4482853A1 (en) 2025-01-01
US20250388632A1 (en) 2025-12-25
WO2023161323A1 (en) 2023-08-31
JP2025506775A (ja) 2025-03-13
CA3249181A1 (en) 2023-08-31

Similar Documents

Publication Publication Date Title
US20230295255A1 (en) Annexin a1-derived polypeptide analogues
US5620955A (en) Bombesin receptor antagonists and uses thereof
CN104822702B (zh) α-MSH和γ-MSH类似物
NZ265452A (en) Analogues of peptide yy, dimers and pharmaceutical compositions
EA036406B1 (ru) Аналоги глюкагона
CZ293113B6 (cs) Peptidový derivát
JPH06503090A (ja) ノナペプチドのボンベシン拮抗薬
WO2023165476A1 (zh) 针对sort1的多肽化合物及其药物偶联物
JP2007526240A (ja) ブラジキニンb1受容体の拮抗薬
EP0574530A1 (en) Endothelin antagonists
WO2015162483A1 (en) Alpha- and gamma-msh analogues
US20150376254A1 (en) Gamma-msh analogues
KR100251496B1 (ko) 헥사펩티드
CN118891273A (zh) 膜联蛋白a1衍生的多肽类似物
US5736517A (en) Treatment of cancer with peptides
CA2507616A1 (en) Highly stable pacap/vip-derived peptides
WO2017068020A1 (en) W-peptide analog
CN113024635B (zh) 一类订书肽化合物及其药物组合物的用途
JP2001226284A (ja) 神経突起誘発剤
TWI237029B (en) Vasoactive intestinal peptide analogs
US6989371B1 (en) Bombesin analogs for treatment of cancer
CN116390938A (zh) 毒蜥外泌肽-4类似物
JP3040166B2 (ja) ノナペプチドのボンベシン拮抗薬
WO2008050161A2 (en) Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds
JPH09512787A (ja) ペプシンの放出を抑制するためのペプチド

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination